SV

Street Verdict

Analyst Scorecard

A record of what Ganesh Dongre said publicly, with the source. Not advice.

Pending — not yet graded
“Recommends buying Sun Pharmaceutical Industries at ₹1615, targeting ₹1650 with a stop loss at ₹1585. A notable bullish reversal pattern has emerged in the short-term trend, suggesting a potential upward movement for the stock.”

Ganesh Dongre’s track record (trackable calls only): 327 graded calls · 95% CI 33–44%

Sun Pharmaceutical IndustriesBullishCalled 11 Mar 2025
Verdict:PENDING

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹1,615, as stated.

Target ₹1,650, stop ₹1,585, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,650 or ₹1,585: there is no fixed window.

Waiting for a close to reach the entry.

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Tracking Sun Pharmaceutical Industries since this call

1-year tracking window
Read the original articleSee Ganesh Dongre’s full track record